Numerous studies demonstrated that the LDOC1 gene inhibits ligand-induced NF-κB activity in oral squamous cell carcinoma (Lee et al., 2013), papillary thyroid carcinoma (Zhao et al., 2015), and pancreatic cancer cells (Nagasaki et al., 2003). This evidence concerns the gene LDOC1 and differentiated thyroid carcinoma.